StockData
HCA Healthcare, Inc. logo

HCA Healthcare, Inc. (HCA) KPIs and segments

HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/303% below fair value
$501.19−10.59 (-2.07%)

Close on Nov 17, 2026Market cap $104.70BP/E 16.6Yield 0.57%

KPI & bộ phận

Chỉ số vận hành và bộ phận làm nên hoạt động của HCA Healthcare · năm tài chính kết thúc ngày 31 tháng 12

Nhìn nhanh KPI của HCA Healthcare: 56 chỉ số vận hành, trong đó có Hospital Network, Bed Capacity — Licensed Beds at End of Period và Consolidated Volume, lấy từ 338 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.

Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.

Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.

Thêm vào biểu đồChỉ số
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
American Group($M)
6,8486,5826,5666,9336,6886,4936,3316,5636,0786,0435,9846,092
Atlantic Group($M)
6,4217,5736,3636,2786,1426,1226,1675,9515,7385,8815,8105,550
National Group($M)
5,7385,2515,3215,4885,5255,2005,0655,0344,9314,8564,8354,765
Corporate and Other($M)
842824859814806790758737740712710896
American Group($M)
21,84621,38521,25121,21720,88920,90020,61420,71419,786
Atlantic Group($M)
18,46719,37418,69117,94517,57317,36517,65417,16816,098
National Group($M)
13,95013,58913,59613,59613,27413,13913,40712,85512,487
Corporate and Other($M)
9,1898,9027,9127,9628,0118,1328,1238,7767,840
Kỳ báo cáo trước đây (báo cáo lần cuối 2026)1
Hospital Network — Number of Hospitals at End of Period2
189190189190191191192190187188188186
Freestanding Outpatient Surgery Centers (ASCs)
117118119121123124125124125123121124
Freestanding Endoscopy Centers
303030312929262623232424
Bed Capacity — Licensed Beds at End of Period3
50,42450,55050,45950,43650,57750,48550,57149,98549,89049,84449,72449,588
Weighted Average Beds in Service
42,86642,90542,84842,98542,89642,85842,86242,70542,64042,62442,56442,072
Occupancy Rate — Weighted Average Beds in Service (%)(%)
73.2%72.7%75.5%72.0%71.7%72.0%76.9%71.7%71.9%71.9%75.2%72.5%
Average Daily Census (ADC — Admitted Inpatient Beds/Day, Form 10-Q/10-K)
29,57130,82929,44229,26629,39931,51829,25829,24729,25930,56729,069
Consolidated Volume — Equivalent Admissions (Inpatient + Outpatient Equivalent)8
1,068,1191,044,3841,023,5751,038,2691,038,7991,017,9941,012,0901,007,6231,006,106994,835981,521974,561
Consolidated Equivalent Admissions — YoY Growth (%)(%)
2.8%2.6%1.1%3.0%3.2%2.3%3.1%3.4%5.0%6.0%7.1%4.6%
Consolidated Inpatient Admissions
592,179579,562580,258576,839577,804566,061576,361559,170562,100554,456560,869544,554
Consolidated Inpatient Admissions — YoY Growth (%)(%)
2.5%2.4%0.7%3.2%2.8%2.1%2.8%2.7%4.5%6.0%6.8%2.7%
Consolidated Inpatient Days (Patient Days)
2,734,4402,690,9232,774,6072,708,6632,692,5132,675,2842,836,6162,691,7102,690,7182,662,5502,781,5962,674,331
Consolidated Inpatient Days — YoY Growth (%)(%)
1.6%0.6%-2.2%0.6%0.1%0.5%2.0%0.6%3.0%4.1%5.4%1.0%
Consolidated Equivalent Patient Days
4,932,9064,850,6334,894,4074,875,9074,842,0274,813,5484,981,0984,850,8204,816,7614,779,2344,867,7934,786,197
Consolidated Equivalent Patient Days — YoY Growth (%)(%)
1.9%0.8%-1.7%0.5%0.5%0.7%2.3%1.4%3.5%4.0%5.7%2.8%
Average Length of Stay (ALOS, days)(ngày)
555555555555
Emergency Care — Consolidated Emergency Room (ER) Visits6
2,607,6422,526,1472,509,0832,511,0092,477,4742,439,7632,518,7162,498,4292,446,9622,414,9602,428,9142,452,395
Consolidated ER Visits — YoY Growth (%)(%)
5.3%3.5%-0.4%0.5%1.2%1.0%3.7%1.9%4.4%5.3%7.8%1.6%
Consolidated Outpatient Surgery Cases (Hospital & ASCs)
242,819246,947240,061264,401253,426258,365246,620263,832249,364258,967252,835270,286
Consolidated Outpatient Surgery Cases — YoY Growth (%)(%)
-4.2%-4.4%-2.7%0.2%1.6%-0.2%-2.5%-2.4%-2.0%-1.8%-1.2%1.8%
Consolidated Inpatient Surgery Cases
136,795133,041133,262136,961138,563136,122133,759135,643135,803135,860133,398132,417
Consolidated Inpatient Surgery Cases — YoY Growth (%)(%)
-1.3%-2.3%-0.4%1.0%2.0%0.2%0.3%2.4%1.7%2.6%2.3%0.4%
Outpatient Revenues as a % of Patient Revenues (%)(%)
38.4%33.7%36.6%39.7%38.3%38.4%37.3%37.9%38.2%38.2%36.9%38.4%
Unit Economics — Consolidated Revenue per Equivalent Admission ($)($)5
18,58319,37018,66918,79418,44618,27618,10218,14617,38117,58317,66617,755
Consolidated Revenue per Equivalent Admission — YoY Growth (%)(%)
0.7%6.0%3.1%3.6%6.1%3.9%2.5%2.2%2.8%4.1%3.9%6.8%
Consolidated Inpatient Revenue per Admission ($)($)
20,05922,52420,29719,84719,90819,65619,34919,73718,72818,81418,92318,992
Consolidated Inpatient Revenue per Admission — YoY Growth (%)(%)
0.8%14.6%4.9%0.6%6.3%4.5%2.3%3.9%2.6%6.4%6.1%7.7%
Days Revenues in Accounts Receivable (DRO, Form 10-Q/10-K)(ngày)
5553515051545452535353
Consolidated Total Revenues — Reported YoY Growth (%)(%)
8.7%4.3%9.6%6.4%5.7%7.9%10.3%11.2%
Same-Facility Benchmarks — Same-Facility Equivalent Admissions14
1,056,6721,035,6101,015,6851,008,4891,008,805990,092987,645980,330985,613975,130960,772959,366
Same-Facility Equivalent Admissions — YoY Growth (%)(%)
3.0%2.7%1.3%2.5%2.4%1.7%2.8%3.1%4.5%5.2%5.2%3.9%
Same-Facility Total Revenues — YoY Growth (%, Form 10-Q/10-K)(%)
9.3%4.5%9.2%5.8%5.7%7.1%9.9%8.8%
Same-Facility Inpatient Admissions
588,020575,979576,766566,249567,382556,544568,265552,610558,105550,610555,681542,628
Same-Facility Inpatient Admissions — YoY Growth (%)(%)
2.7%2.5%0.9%2.4%2.1%1.8%2.6%3.0%4.5%5.8%6.2%3.1%
Same-Facility Revenue per Equivalent Admission ($)($)
18,61419,39118,69218,70818,39018,11018,04718,18517,31117,50317,56917,672
Same-Facility Revenue per Equivalent Admission — YoY Growth (%)(%)
0.6%6.4%3.1%2.9%6.6%4.0%2.9%2.9%2.5%4.4%3.5%6.9%
Same-Facility Inpatient Revenue per Admission ($)($)
20,09522,56620,32719,87519,98119,57619,37019,83518,79318,84518,96419,025
Same-Facility Inpatient Revenue per Admission — YoY Growth (%)(%)
0.6%15.4%5.0%0.6%7.1%4.5%2.4%4.4%3.2%6.4%6.6%8.5%
Same-Facility Emergency Room (ER) Visits
2,585,8112,507,8242,493,9712,467,1752,439,4052,401,6842,486,4892,466,7842,433,8872,400,2482,400,1902,445,405
Same-Facility ER Visits — YoY Growth (%)(%)
5.1%3.6%0.3%0.5%1.3%1.3%4.0%2.4%4.6%5.5%7.2%2.1%
Same-Facility Outpatient Surgery Cases
237,263242,395236,326258,540248,367253,006242,471257,663244,733254,371247,721263,398
Same-Facility Outpatient Surgery Cases — YoY Growth (%)(%)
-3.7%-3.4%-1.7%-0.5%1.1%-0.6%-2.1%-1.3%-2.0%-2.1%-2.1%0.7%
Same-Facility Inpatient Surgery Cases
135,620132,312132,568134,971136,467134,307132,303134,482134,913135,129132,274132,056
Same-Facility Inpatient Surgery Cases — YoY Growth (%)(%)
-1.4%-2.3%-0.3%0.0%1.4%-0.3%0.2%2.8%1.6%2.6%1.7%1.0%
Hospitals by Operating Group — Total Consolidated Hospitals (Note 12 XBRL)5
190189190191191192190187188188186
American Group — Number of Hospitals
6666666666666562626260
Atlantic Group — Number of Hospitals
6463636363636262626262
National Group — Number of Hospitals
5353535454555555565657
Corporate and Other (including UK) — Number of Hospitals
77888888887
Geographic Presence — Total U.S. States & Countries Operated
1919192020202020202020
Payor Mix — Managed Care and Other Insurers Revenue($M)12
9,0139,0849,5369,2679,1249,0419,3638,4978,5498,5458,679
Managed Care and Other Insurers — Share of Total Revenues (%)(%)
44.6%47.5%48.4%49.1%49.4%48.6%48.7%49.2%
Managed Medicare (Medicare Advantage) Revenue($M)
3,4243,5083,4783,3063,3523,2993,0992,9492,9133,0262,861
Managed Medicare — Share of Total Revenues (%)(%)
16.9%18.4%17.3%18.0%18.0%16.9%16.7%17.4%
Medicare Fee-for-Service (Traditional Medicare) Revenue($M)
2,9273,0582,8472,7282,8032,8952,7372,5842,6212,8382,720
Medicare Fee-for-Service — Share of Total Revenues (%)(%)
14.5%16.0%14.2%15.1%15.8%14.8%15.0%16.4%
Medicaid Fee-for-Service (including State Directed/Supplemental Payments) Revenue($M)
2,7891,4441,4961,7831,4401,1901,3621,1271,1661,0001,128
Medicaid Fee-for-Service — Share of Total Revenues (%)(%)
13.8%7.6%9.3%7.7%6.5%6.4%6.7%5.8%
Managed Medicaid Revenue($M)
9979399669498998799381,0311,0339781,033
Managed Medicaid — Share of Total Revenues (%)(%)
4.9%4.9%4.9%4.8%4.8%5.9%5.9%5.6%
International (United Kingdom) Revenue($M)
491499474484461445430424416412382
International (UK) — Share of Total Revenues (%)(%)
2.4%2.6%2.5%2.5%2.4%2.4%2.4%2.4%
Other Revenue — Share of Total Revenues (%)(%)
2.9%3.0%3.4%2.8%3.1%5.0%4.6%3.2%
Uncompensated Care — Total Uncompensated Care Charges Forgone (Gross Charges)($M)4
15,07613,61213,33312,01511,62510,99311,66010,95810,61110,0029,910
Estimated Cost of Total Uncompensated Care (at Cost-to-Charges Ratio)($M)
1,4451,2521,2461,1881,1161,0551,1461,1381,0721,0101,015
Charity Care & Indigent Care — Gross Charges Forgone($M)
5,3185,5134,6124,1314,1123,6443,8514,0014,1123,9783,741
Estimated Cost of Charity Care($M)
511507431408395350377416415402382
Hospital Cost-to-Charges Ratio (%)(%)
9.2%10.0%9.7%9.6%10.3%10.1%10.1%
Hospital Cost Structure — Salaries and Benefits Expense($M)1
8,5818,2908,2838,3608,3648,1387,9977,9177,8617,6857,7077,570
Salaries and Benefits — % of Revenues (%)(%)
43.2%41.0%43.3%42.8%43.6%43.7%43.6%43.3%45.0%43.9%44.4%43.7%
Hospital Cost Structure — Supplies Expense (Medical Devices, Pharmacy & Surgical)($M)1
2,8222,8862,8532,9772,7822,8442,7642,7932,6572,6342,6712,584
Supplies Expense — % of Revenues (%)(%)
14.2%14.3%14.9%15.3%14.5%15.3%15.1%15.3%15.2%15.1%15.4%14.9%
Hospital Cost Structure — Other Operating Expenses (Contract Services, Utilities, Insurance, Rent)($M)2
4,5485,0434,1804,0874,1613,7933,8453,8733,7173,6233,6063,559
Other Operating Expenses — % of Revenues (%)(%)
23.0%24.9%21.9%20.9%21.8%20.4%21.0%21.2%21.2%20.7%20.9%20.7%
Total Patient Care Operating Costs (Salaries + Supplies + Other OpEx, XBRL)($M)
16,24616,33516,19615,63815,46615,43915,07714,76114,77914,502
Non-GAAP Profitability — Adjusted EBITDA($M)7
3,9184,0273,8024,1143,8703,8493,7333,7123,2673,5503,3533,618
Adjusted EBITDA Margin (% of Revenues)(%)
19.7%19.9%19.9%21.1%20.2%20.7%20.4%20.3%18.7%20.3%19.3%20.9%
Adjusted Net Income Attributable to HCA Healthcare, Inc.($M)
1,5691,6911,6211,8471,6441,6561,6091,5871,2731,4521,4371,598
Adjusted Diluted Earnings per Share ($/sh)($)
7.227.597.158.016.966.846.456.224.905.505.365.90
Depreciation and Amortization — % of Revenues (%)(%)
4.8%4.6%4.8%4.7%4.7%4.7%4.7%4.6%4.9%4.7%4.5%4.5%
Interest Expense — % of Revenues (%)(%)
3.1%3.0%3.1%2.9%2.9%3.0%3.0%2.9%2.9%2.9%3.0%2.8%
Income Before Income Taxes — % of Revenues (%)(%)
11.9%12.3%12.0%13.7%12.6%13.0%12.7%11.7%10.9%12.8%13.0%13.6%
Net Income Attributable to HCA Healthcare, Inc. — % of Revenues (%)(%)
8.0%8.4%8.5%9.6%8.6%8.9%8.8%7.9%7.3%8.4%9.2%9.3%
Professional Liability Reserves — Net Reserves (Net of Reinsurance Recoverable) at December 313
Gross Reserves for Professional Liability Risks — Total (Balance Sheet)($M)
2,0442,1312,089
Reserves for Professional Liability Risks — Non-Current($M)
1,4641,5091,4661,4621,5061,4971,5441,5841,5731,5711,557
Reserves for Professional Liability Risks — Current (in Other Accrued Expenses)($M)
578587532
American Group (TX, CO, KS, MO, LA, UT, ID, AK) — Segment Revenues($M)8
6,5826,5666,9336,6886,4936,3316,5636,0786,0435,9846,092
American Group — Segment Adjusted EBITDA($M)
1,3691,4141,7201,5801,5781,4181,6341,3641,4131,318
American Group — Salaries and Benefits($M)
2,2872,2772,3052,2752,2162,1962,1942,1762,110
American Group — Supplies Expense($M)
1,0841,0591,1231,0531,0671,0201,0701,007978
American Group — Other Operating Expenses($M)
1,8591,8311,8061,7961,6491,7111,6781,5491,560
American Group — Total Operating Expenses (less Equity Earnings)($M)
5,2135,1525,2135,1084,9154,9134,9294,7144,630
American Group — Equity in Earnings of Affiliates($M)
171521161714131818
American Group — Depreciation and Amortization($M)
296295292283277279284277267255252
American Group — Goodwill and Intangible Assets($M)
5,6885,5865,478
Atlantic Group (FL, TN, NC, SC, VA, NH, KY) — Segment Revenues($M)8
7,5736,3636,2786,1426,1226,1675,9515,7385,8815,8105,550
Atlantic Group — Segment Adjusted EBITDA($M)
1,8271,4391,4891,3391,3521,4621,2391,1351,3051,259
Atlantic Group — Salaries and Benefits($M)
2,2932,2862,2732,2882,2462,2162,1862,1902,149
Atlantic Group — Supplies Expense($M)
934944951889935914902858884
Atlantic Group — Other Operating Expenses($M)
2,5201,6951,5651,6271,5901,5761,6251,5551,544
Atlantic Group — Total Operating Expenses (less Equity Earnings)($M)
5,7464,9244,7894,8034,7704,7054,7124,6034,576
Atlantic Group — Equity in Earnings of Affiliates($M)
110111101
Atlantic Group — Depreciation and Amortization($M)
298298292281275274271271261258254
Atlantic Group — Goodwill and Intangible Assets($M)
2,2142,1242,064
National Group (CA, NV, GA, FL-West, VA-North, etc.) — Segment Revenues($M)8
5,2515,3215,4885,5255,2005,0655,0344,9314,8564,8354,765
National Group — Segment Adjusted EBITDA($M)
1,1841,2581,3521,3481,2711,1321,1901,0681,0871,047
National Group — Salaries and Benefits($M)
1,9651,9661,9641,9701,9191,9591,8861,8971,869
National Group — Supplies Expense($M)
773763805742755741718696693
National Group — Other Operating Expenses($M)
1,3301,3341,3671,4661,2551,2331,2401,2701,204
National Group — Total Operating Expenses (less Equity Earnings)($M)
4,0674,0634,1364,1773,9293,9333,8443,8633,769
National Group — Equity in Earnings of Affiliates($M)
10010000-3
National Group — Depreciation and Amortization($M)
238236230226223226220214211212213
National Group — Goodwill and Intangible Assets($M)
1,2341,2371,241
Corporate and Other (including United Kingdom Operations) — Revenues($M)4
824859814806790758737740712710896
Corporate and Other — Adjusted EBITDA (Net Expense / Contribution)($M)
353309447397352279351300255271
Total Reportable Operating Segments Adjusted EBITDA (American + Atlantic + National)($M)
4,3804,1114,5614,2674,2014,0124,0633,5673,8053,624
Corporate and Other — Depreciation and Amortization($M)
112101979988818180807070
Corporate and Other — Goodwill and Intangible Assets($M)
1,1571,1461,162
Hospital Peer — Universal Health Services (UHS): Total Revenues($M)2
4,6384,4954,4864,4954,2844,1004,1143,9633,9083,8443,704
Universal Health Services (UHS) — GAAP Operating Income($M)
517503517522500455472384436389331
Universal Health Services (UHS) — Medical Claims & Liabilities($M)
160155152149147145137136134132130
Hospital Peer — Community Health Systems (CYH): Total Revenues($M)1
2,8252,9653,1063,0873,1333,1593,2653,0903,1403,1403,182
Community Health Systems (CYH) — GAAP Operating Income($M)
389281450243512284278-205238231327
Post-Acute / Rehab Peer — Encompass Health Corporation (EHC): Total Revenues($M)
1,5971,5871,5451,4781,4581,4551,4051,3511,3011,3161,247
Behavioral Health Peer — Acadia Healthcare Company (ACHC): Total Revenues($M)
829821852869771774816796768743
Ambulatory Surgery Peer — Surgery Partners, Inc. (SGRY): GAAP Operating Income($M)
1026611010611262127618576101
Skilled Nursing Peer — The Ensign Group (ENSG): Total Revenues($M)1
1,4841,4401,3891,3611,2961,2281,1731,1321,0821,0361,010959
The Ensign Group (ENSG) — GAAP Operating Income($M)
1381231251249610410110189868223
Outpatient Dialysis & Lab Peers — DaVita Inc. (DVA): Total Revenues($M)3
3,5543,4163,6203,4203,3803,2243,2953,2643,1873,0713,146
DaVita Inc. (DVA) — GAAP Operating Income($M)
579482561506538439565535506484390
Quest Diagnostics (DGX) — Total Revenues($M)
3,0973,0432,8952,8062,8162,7612,6522,6212,4882,3972,3662,288
Quest Diagnostics (DGX) — GAAP Operating Income($M)
479459399386386438346361330355300267
Managed Care Payer Benchmarks — UnitedHealth Group (UNH): Total Revenues($M)3
112,032111,721113,215113,161111,616109,575100,807100,82098,85599,79694,427
UnitedHealth Group (UNH) — GAAP Operating Income($M)
7,9918,9903804,3155,1509,1197,7738,7087,8757,9317,689
CVS Health Corporation (CVS / Aetna) — Total Revenues($M)
106,096100,426105,693102,87198,91594,58897,71095,42891,23488,43793,813
CVS Health Corporation (CVS / Aetna) — GAAP Operating Income($M)
4,7034,6802,112-3,2072,3813,3742,3688323,0452,2713,373
U.S. Census QSS — Hospitals Taxable Employer Revenue (NAICS 622, NSA)($M)5
47,89646,67446,83446,29545,37045,35845,28443,77843,50543,70943,264
Census QSS — Ambulatory Health Care Services Revenue (NAICS 621, NSA)($M)
414,886395,174407,176398,164389,960373,423380,950366,854362,208347,178347,128
Census QSS — Outpatient Care Centers Revenue (NAICS 6214, NSA)($M)
45,10844,02245,30042,79741,83240,03040,60237,89737,22736,08737,030
Census QSS — Medical & Diagnostic Laboratories Revenue (NAICS 6215, NSA)($M)
20,52819,56919,99719,67719,71818,72219,10418,89318,48317,96317,943
BEA Personal Consumption Expenditures — Health Care Services (SAAR)
3,790.303,699.903,667.003,614.903,529.803,464.703,417.803,358.203,288.203,244.403,159.40
BEA Real PCE — Health Care Quantity Index (2017=100)(×)
135.90133.60133.60132.70130.40129.00127.90126.70124.80123.80121.50
DB Consolidated Income Statement — Total Revenues($M)16
19,84920,23019,10919,51319,16118,60518,32118,28517,48717,49217,33917,303
DB Consolidated — Total Operating Costs and Expenses($M)
17,73616,82216,84116,74316,19015,99416,15215,58115,25515,09214,958
DB Consolidated — General & Administrative / Other Operating Expenses($M)
14813315313913012612011110090100
DB Consolidated — Depreciation and Amortization($M)
954944930911889863860856842819795789
DB Consolidated — Equity in Earnings of Affiliates($M)
1692516191810150-228
DB Consolidated — Gains (Losses) on Sales of Facilities($M)
10-141-2-31-195-4122017
DB Consolidated — Interest Expense($M)
607599584572561568547528515506512491
DB Consolidated — Income Before Income Taxes($M)
2,3702,4942,2872,6722,4182,4152,3272,1331,9062,2372,2472,345
DB Consolidated — Provision for Income Taxes($M)
521564430509515524502447424550445484
DB Consolidated — Net Income (Consolidated)($M)
1,9301,8572,1631,9031,8911,8251,6861,4821,6871,8021,861
DB Consolidated — Net Income Attributable to Noncontrolling Interests($M)
270231237285260238215248212226211254
DB Consolidated — Net Income Attributable to HCA Healthcare, Inc.($M)
1,5791,6991,6201,8781,6431,6531,6101,4381,2701,4611,5911,607
DB Consolidated — Diluted Earnings per Share ($/sh)($)
7.277.627.158.146.966.836.455.634.885.535.935.93
DB Consolidated — Basic Earnings per Share ($/sh)($)
7.707.257.056.916.524.945.606.01
DB Consolidated — Weighted Average Diluted Shares (millions)(M)
217223227231236242249255260264268271
DB Consolidated — Weighted Average Basic Shares (millions)(M)
221224233239247257261264
DB Consolidated — Cash Dividends Declared per Share ($/sh)($)
0.780.780.720.720.720.720.660.660.660.660.60
DB Consolidated Balance Sheet — Total Assets($M)36
63,25061,45060,72059,74759,53659,79859,51359,45957,37956,96256,211
DB Balance Sheet — Cash and Cash Equivalents($M)
1,0139401,0409979391,0601,9332,8888311,284935
DB Balance Sheet — Accounts Receivable, Net($M)
12,28111,32410,86710,42810,45911,08810,7519,91510,23910,0449,958
DB Balance Sheet — Inventories($M)
1,6621,6811,6521,7341,7921,7941,7381,7761,8001,9032,021
DB Balance Sheet — Other Current Assets($M)
2,2342,1072,2242,1262,3732,3161,9922,0832,3032,0512,013
DB Balance Sheet — Total Current Assets($M)
17,19016,05215,78315,28515,56316,25816,41416,66215,17315,28214,927
DB Balance Sheet — Property and Equipment, at Cost (Gross)($M)
68,40967,36566,27565,48964,38863,68062,51461,75060,62559,44058,548
DB Balance Sheet — Accumulated Depreciation($M)
-36,593-35,893-35,134-34,921-34,265-33,942-33,100-32,703-31,986-31,344-30,833
DB Balance Sheet — Property and Equipment, Net($M)
31,81631,47231,14130,56830,12329,73829,41429,04728,63928,09627,715
DB Balance Sheet — Land($M)
3,4153,2953,120
DB Balance Sheet — Buildings($M)
23,72622,69121,560
DB Balance Sheet — Equipment & Machinery($M)
36,98934,67031,998
DB Balance Sheet — Construction in Progress($M)
2,1451,8581,870
DB Balance Sheet — Right-of-Use Operating Lease Assets($M)
2,1092,0942,1302,1152,1562,1322,1312,2012,1792,2112,207
Right-of-Use Finance Lease Assets (XBRL)($M)
607646556
Total Lease Right-of-Use Assets (Operating + Finance, XBRL)($M)
2,7372,7772,763
DB Balance Sheet — Investments of Insurance Subsidiaries($M)
402387485573531550569553483471477
DB Balance Sheet — Investments in and Advances to Affiliates($M)
813615633654654657662705702736756
Goodwill and Other Intangible Assets, Net (XBRL)($M)
10,66210,50410,29310,27510,27310,23710,0939,9829,9639,9679,945
DB Balance Sheet — Other Long-Term Assets($M)
258326255277236226230309240199184
DB Balance Sheet — Accounts Payable($M)
4,7524,8064,6594,5524,2504,4884,2764,2354,0294,7354,233
Accrued Salaries and Benefits (Current, XBRL)($M)
2,1992,0222,5252,2942,0721,8572,3042,1641,9931,7592,127
Other Accrued Expenses (Current, XBRL)($M)
4,0973,8984,2774,9404,5133,7673,8993,8193,7053,6193,871
DB Balance Sheet — Short-Term Borrowings & Long-Term Debt Due Within One Year($M)
6,2648,5324,8896,1105,1044,698
DB Balance Sheet — Total Current Liabilities($M)
17,31219,25816,35017,89615,93913,63115,17714,90014,30113,14112,655
DB Balance Sheet — Long-Term Debt, Less Current Portion($M)
43,45439,49141,60338,40139,37941,05738,33338,28336,30637,16337,169
DB Balance Sheet — Right-of-Use Operating Lease Obligations (Non-Current)($M)
1,8341,8221,8531,8381,8811,8601,8631,9241,8941,9121,903
DB Balance Sheet — Operating Lease Liabilities (Current)($M)
352343363
DB Balance Sheet — Total Operating Lease Liabilities($M)
2,2052,2062,266
Total Finance Lease Liabilities (XBRL)($M)
758786707
Total Lease Liabilities (Operating + Finance, XBRL)($M)
2,9632,9922,973
DB Balance Sheet — Retained Earnings (Accumulated Deficit)($M)
-6,310-5,978-5,724-5,020-4,087-3,164-2,115-1,807-1,170-1,185-1,352
DB Balance Sheet — Accumulated Other Comprehensive Loss($M)
-334-327-305-317-309-357-387-378-433-433-425
DB Balance Sheet — Stockholders' Deficit Attributable to HCA Healthcare, Inc.($M)
-6,642-6,303-6,027-5,335-4,394-3,519-2,499-2,182-1,600-1,615-1,774
DB Balance Sheet — Noncontrolling Interests in Consolidated Entities($M)
3,4333,3253,2563,1763,1563,0813,0542,9682,9392,8852,834
DB Balance Sheet — Total Stockholders' Deficit / Equity($M)
-3,209-2,978-2,771-2,159-1,238-4385557861,3391,2701,060
DB Balance Sheet — Common Shares Outstanding at Period-End (millions)(M)
218223225230236243250255259263266
DB Consolidated Cash Flow — Net Cash Provided by Operating Activities($M)18
2,3352,0142,3594,4164,2101,6512,5593,5151,9712,4692,674
DB Cash Flow — Purchase of Property and Equipment (CapEx, excluding Acquisitions)($M)
1,2311,1191,4891,2881,1769911,2851,1911,2811,1181,159
DB Cash Flow — Depreciation and Amortization($M)
944930911889863860856842819795789
DB Cash Flow — Share-Based Compensation($M)
8586100104999885761128757
DB Cash Flow — Deferred Income Taxes($M)
-166435-1,00443438849289-63-448444168
DB Cash Flow — Change in Accounts Receivable($M)
-954-463-43925647-327-854340-195-90-767
DB Cash Flow — Change in Accounts Payable and Accrued Expenses($M)
551-990637705324-1,00028253658-517393
DB Cash Flow — Net Cash Used in Investing Activities($M)
-1,557-1,282-1,317-1,388-1,251-1,032-1,346-1,352-1,332-903-1,597
DB Cash Flow — Sales of Hospitals and Health Care Entities($M)
18392106161161131010
DB Cash Flow — Net Cash Used in Financing Activities($M)
-704-830-999-2,967-3,089-1,495-2,163-110-1,093-1,216-1,039
DB Cash Flow — Issuances of Long-Term Debt($M)
2,99403,241005,23303,01204,4834
DB Cash Flow — Repayment of Long-Term Debt($M)
2,550581,5551741,7653,89564772032,066218
Distributions to Noncontrolling Interests (XBRL)($M)
143191196237174220181192186152143
DB Cash Flow — Payment of Cash Dividends($M)
171183162166171180165169171185160
DB Cash Flow — Repurchase of Common Stock ($M)($M)
2,0641,5712,5582,4982,5052,5061,7001,7951,3671,180910
Common Shares Repurchased (millions, XBRL)(M)
4.753.165.436.517.037.764.744.954.223.893.65
Average Repurchase Price per Share ($/sh, XBRL)($)
498323303
DB Cash Flow — Interest Paid($M)
594569511622535539533462405538432
DB Cash Flow — Income Taxes Paid($M)
730-51,51381136103584879981316
Debt Structure & Lease Maturity — Gross Debt Principal / Carrying Value (XBRL)($M)16
50,16948,45646,92844,92744,91245,00843,40043,34341,25140,57239,926
Estimated Fair Value of Total Debt (XBRL)($M)
48,64046,65345,91143,89843,20142,87640,84542,59339,08638,62638,253
Senior Unsecured Notes Carrying Value (XBRL)($M)
44,20043,70043,70041,95042,07543,76641,11641,11638,11638,26635,766
Commercial Paper & Short-Term Credit Facility Borrowings (XBRL)($M)
3,8903,6502,2071,9101,7780
Average Debt Balance During Period (MD&A)($M)
49,22847,22544,40044,50643,74641,84640,29240,383
Weighted Average Stated Interest Rate on Debt (XBRL, %)(%)
5.1%5.1%5.1%5.1%5.1%5.2%5.1%5.1%5.1%5.1%5.1%
Average Effective Interest Rate on Long-Term Debt (MD&A, %)(%)
4.9%5.0%5.1%4.9%5.1%
Operating Lease Maturity — Total Undiscounted Lease Payments($M)
3,2193,1663,242
Operating Lease Maturity — Year 1($M)
474455452
Operating Lease Maturity — Year 2($M)
413405394
Operating Lease Maturity — Year 3($M)
343344340
Operating Lease Maturity — Year 4($M)
276281288
Operating Lease Maturity — Year 5($M)
214221228
Operating Lease Maturity — Thereafter (After Year 5)($M)
1,4991,4601,540
Operating Lease Weighted-Average Discount Rate (%)(%)
5.3%5.1%4.9%
Finance Lease Weighted-Average Discount Rate (%)(%)
5.6%5.3%4.9%
Unrecognized Tax Benefits Balance (Note 5 XBRL)($M)
519504639

16 chỉ số không có số liệu trong 12 quý gần nhất — .

In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).

Phương pháp và các chỉ số bị loại
  • Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
  • Fiscal calendar: HCA Healthcare, Inc. operates on a calendar fiscal year ending December 31 (Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4 ends Dec 31). Latest reported company period: Q3 2026 (ended September 30, 2026, filed October 27, 2026 on Form 8-K Item 2.02) for all Operating Statistics, Same-Facility metrics, Non-GAAP Adjusted EBITDA, and headline financial statements; Q2 2026 (ended June 30, 2026, filed July 28, 2026 on Form 10-Q) for 10-Q footnote disclosures (Payor Source breakdown, Uncompensated Care, Segment EBITDA/OpEx, Average Daily Census, and Days Revenues in Accounts Receivable); and Full-Year FY2025 (ended December 31, 2025, filed February 10, 2026 on Form 10-K and March 13, 2026 on DEF 14A).
  • Bed & Occupancy Definition Change (Q1 2021): Beginning in the FY2020 Q4 / FY2021 Form 8-K and Form 10-K (with comparative FY2019 recast), HCA transitioned its capacity utilization metric from Weighted Average Licensed Beds to Weighted Average Beds in Service (and Occupancy Rate based on Weighted Average Beds in Service, including observation patients). Both the current Beds in Service series (FY2019–FY2026Q3) and legacy Licensed Beds occupancy series (FY2014–FY2020Q3) are preserved.
  • Geographic Operating Groups (Group 4): HCA manages and reports its U.S. hospital network across three geographic operating groups — American Group (66 hospitals in Q2 2026), Atlantic Group (64 hospitals), and National Group (53 hospitals) — plus Corporate and Other (including 7–8 international hospitals in England). Segment Adjusted EBITDA and segment expense breakdowns (Salaries & benefits, Supplies, Other operating expenses) are extracted from Note 12 (Segment and Geographic Information) XBRL tags.
  • Parent-Company Standalone Evaluation (Step 3): HCA Healthcare, Inc. is a holding company with no standalone parent-company operating revenue ($0 direct patient revenue; all hospitals and surgery centers are operated by consolidated subsidiaries and partnerships). Therefore, Consolidated − Standalone subtraction does not apply.
  • Strict Step 4 & Step 5 Compliance: Every cell displays an exact point figure published by HCA Healthcare or official external industry sources (CMS Medicaid Enrollment Reports, Census QSS/BLS/BEA via FRED, SEC XBRL hospital peer filings), plus permitted period splits (Q4 = full year − nine months and quarterly flow = year-to-date − prior quarter year-to-date, marked in italics with formula). Bound/approximate prose figures ('approximately 2,400 ambulatory sites of care', 'approximately 47 million patient encounters', 'approximately 320,000 employees', 'more than 5,400 GME residents') are excluded from table cells and cataloged in `excluded`.

Không hiện vì thiếu các kỳ gần đây (8)

  • Total outpatient sites of care ('approximately 2,400 ambulatory sites of care' / 'approximately 2,500 outpatient facilities') — Approximate figures ('approximately 2,400', 'approximately 2,500') — excluded; exact point figures were obtained for major components disclosed in tables: Freestanding Outpatient Surgery Centers (ASCs: 117 as of Q3 2026) and Freestanding Endoscopy Centers (30 as of Q3 2026).
  • Annual patient encounters ('approximately 47 million patient encounters' in FY2025; 'approximately 44 million' in FY2024) — Approximate figures ('approximately 47 million', 'approximately 44 million') — excluded; exact quarterly and annual series are available for Admissions (2,297,065 in FY2025), Equivalent Admissions (4,107,152), Emergency Room Visits (9,946,962), and Inpatient/Outpatient Surgeries.
  • Headquarters square footage in Nashville, TN ('approximately 2,002,000 square feet' in FY2025; 'approximately 2,031,000 square feet' in FY2022–FY2024) — Approximate figures ('approximately 2,002,000 square feet') — excluded.
  • Item 1 narrative employee headcount ('approximately 320,000 employees, including approximately 90,000 part-time and PRN employees') and active staff physicians ('approximately 44,000 active and affiliated physicians') & nurses ('approximately 99,000 registered nurses') — Approximate figures ('approximately 320,000', 'approximately 90,000', 'approximately 44,000', 'approximately 99,000') — excluded; replaced with exact headcount data from the DEF 14A CEO Pay Ratio table (Total Global Workforce = 316,971; Total U.S. Employees = 308,398; Total International Employees = 8,573 as of year-end FY2025).
  • Graduate Medical Education (GME) residents & fellows ('more than 5,400 residents and fellows' / 'nearly 2,000 new residents and fellows') — Approximate figures ('more than 5,400', 'nearly 2,000') — excluded.
  • HCA Healthcare Research Institute active clinical trials ('more than 500 active trials') — Approximate figures ('more than 500') — excluded.
  • Behavioral & rehabilitation hospital counts in Item 1 narrative ('seven behavioral hospitals, and four rehabilitation hospitals') — Disclosed as text words ('seven', 'four') rather than digits in narrative disclosures — excluded; exact numerical data was captured for Total Hospitals (190) and General Acute Care Hospitals (179).
  • State hospital & bed counts in Oklahoma (2 hospitals, 756 beds in FY2016–FY2017) and Mississippi (1 hospital, 130 beds in FY2016–FY2019) — HCA divested all hospitals in Oklahoma (after FY2017) and Mississippi (after FY2019), with no data available for the 2 most recent fiscal years (FY2024–FY2025).

Dữ liệu cập nhật 2026-10-29.

Mỗi KPI một trang riêng

Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số

5. Clinical Quality Scorecard, Patient Experience, Workforce & CEO Pay Ratio (DEF 14A Proxy Statements, FY2022–FY2025)

Tài liệu nguồn mới nhất

Các tài liệu được trích nhiều nhất cho số liệu mới nhất của HCA Healthcare

See a number that looks wrong?